Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-030961

Chief Financial Officer sold 57,766 shares at an average $89.12 ($5,148,024)

  • Chief Financial Officer acquired 47,890 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bonstein Sara · Chief Financial Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-10 Exercise or conversion : show line 1 in the form 10b5-1 +24,150 $18.95 $457,643 137,438 D
2025-06-10 Exercise or conversion : show line 2 in the form 10b5-1 +23,740 $17.07 $405,242 161,178 D
2025-06-10 Sale : show line 3 in the form 10b5-1 −7,277 $87.12 $633,972 153,901 D
2025-06-10 Sale : show line 4 in the form 10b5-1 −7,310 $88.29 $645,400 146,591 D
2025-06-10 Sale : show line 5 in the form 10b5-1 −20,926 $88.99 $1,862,205 125,665 D
2025-06-10 Sale : show line 6 in the form 10b5-1 −15,825 $89.85 $1,421,876 109,840 D
2025-06-10 Sale : show line 7 in the form 10b5-1 −6,328 $90.93 $575,405 103,512 D
2025-06-10 Sale : show line 8 in the form 10b5-1 −100 $91.66 $9,166 103,412 D
Open-market sales · 57,766 sh · avg $89.12 · $5,148,024

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-06-10 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −24,150 134,260 D
2025-06-10 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) −23,740 35,610 D
Loading xslF345X05/wk-form4_1749759395.xml…